Literature DB >> 6131738

Binding of [3H]des-Arg9-BK to rabbit anterior mesenteric vein.

J Barabé, C Babiuk, D Regoli.   

Abstract

Binding studies of [3H]des-Arg9-BK have been performed on pieces of rabbit anterior mesenteric veins. Kinetic studies have permitted us to evaluate an affinity constant of 1.04 X 10(-7) M, which is not so different from the apparent affinity constant determined by bioassay (1.6 X 10(-7) M). Furthermore, inhibition of the binding of [3H]des-Arg9-BK with various kinins results in an order of potency of kinins very similar to that observed in the bioassay. Taken together, these results suggest that we are dealing with binding sites which might be the same as those subserving the biological action of des-Arg9-BK (pharmacological receptors). The preincubation of tissues in Krebs' solution brings about an increase of the specific binding from 0.06 pmol/mg of wet weight at time 0 to 0.75 pmol after 24 h; cycloheximide inhibits this increase for at least 6 h. Veins taken from animals treated with LPS, which have shown an increase in sensitivity compared with veins extracted from untreated animals, have a higher number of specific binding sites for [3H]des-Arg9-BK. The results support the hypothesis that the increased response of tissues to des-Arg9-BK is due to the de novo synthesis of receptors for kinins in some experimental and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6131738     DOI: 10.1139/y82-229

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  The human bronchus model in vitro. Pharmacological approach of various components involved in the functional response.

Authors:  M Molimard; C Advenier
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

2.  Selective labelling of bradykinin receptor subtypes in WI38 human lung fibroblasts.

Authors:  S B Phagoo; M Yaqoob; M C Brown; G M Burgess
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Evidence for BK1 bradykinin-receptor-mediated prostaglandin formation in osteoblasts and subsequent enhancement of bone resorption.

Authors:  O Ljunggren; U H Lerner
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery.

Authors:  G R Drummond; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production.

Authors:  J P Galizzi; M C Bodinier; B Chapelain; S M Ly; L Coussy; S Giraud; G Neliat; T Jean
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

6.  Characterization of bradykinin receptors mediating catecholamine release in PC12 cells.

Authors:  A Dendorfer; P Dominiak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.